Carcinogen treatment in mouse selectively expressing activated N-Ras Q61K in melanocytes recapitulates metastatic...

Area of Science:

• Oncology
• Dermatology
• Genetics

Background:

• Melanoma incidence is rising, necessitating improved understanding of its pathogenesis and novel therapeutic approaches.
• Current research requires robust models that accurately recapitulate human metastatic melanoma.
• The TyrRas-DMBA mouse model offers a new platform for investigating melanoma development.

Purpose of the Study:

• To establish and characterize a novel murine model for metastatic cutaneous melanoma.
• To evaluate the model's fidelity in mimicking human melanoma progression and metastasis.
• To provide a tool for preclinical studies of melanoma pathogenesis and therapy.

Main Methods:

• Utilized C57BL/6 mice expressing a mutated human N-Ras gene under a tyrosinase promoter (TyrRas).
• Administered topical 7,12-dimethylbenzanthracene (DMBA) exposure for induction of cutaneous melanoma.
• Assessed melanoma development, incidence, and metastatic potential to lymph nodes.
• Evaluated transplantability of melanoma cells from the model into non-transgenic mice.

Main Results:

• Cutaneous melanoma developed in 80% of TyrRas-DMBA mice by 19 weeks of age at the site of DMBA exposure.
• Melanoma development was consistently associated with metastasis to tumor-draining lymph nodes, mirroring human pathology.
• Intradermal inoculation of melanoma cells from these mice into non-transgenic recipients resulted in tumor growth and lymph node metastasis.

Conclusions:

• The TyrRas-DMBA mouse model effectively recapitulates metastatic cutaneous melanoma, including lymph node metastasis.
• This model provides a valuable preclinical tool for studying melanoma pathogenesis and evaluating novel therapeutic strategies.
• The transplantable nature of the melanoma in this model enhances its utility for drug screening and mechanistic studies.